Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy
about
Placental transfer of antidepressant medications: implications for postnatal adaptation syndromePharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoringHuman Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic MetabolismGene structure of CYP2C8 and extrahepatic distribution of the human CYP2CsDetection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytesXenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicityInduction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell lineThe trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine but not trichloroacetate inhibits pathogen-stimulated TNF-α in human extraplacental membranes in vitroThe role of CYP2B6 in human xenobiotic metabolism.Bupropion metabolism by human placenta.Human variability and susceptibility to trichloroethylenePharmacokinetics of indomethacin in pregnancy.Diabetes and hypertension increase the placental and transcellular permeation of the lipophilic drug diazepam in pregnant women.Maternal drug abuse and human term placental xenobiotic and steroid metabolizing enzymes in vitro.Transplacental Distribution of Lidocaine and Its Metabolite in Peridural Anesthesia Administered to Patients With Gestational Diabetes MellitusGestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant miceA Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine Pharmacokinetics.The fate and effects of xenobiotics in human placenta.Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans.Alterations in drug disposition during pregnancy: implications for drug therapy.Excretion of biliary compounds during intrauterine life.Pharmacokinetics in special populations.Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues.Foetal exposure to food and environmental carcinogens in human beings.Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier.The pattern of xenobiotic-metabolizing enzymes in the human pancreas.Pulmonary cytochrome P450 monooxygenase and Clara cell differentiation in mice.Characterization of Maternal and Fetal CYP3A-Mediated Progesterone Metabolism.Co-culture of JEG-3, BeWo and syncBeWo cell lines with adrenal H295R cell line: an alternative model for examining endocrine and metabolic properties of the fetoplacental unit.Porcine microsomal vitamin D(3) 25-hydroxylase (CYP2D25). Catalytic properties, tissue distribution, and comparison with human CYP2D6.Physiology and Pathophysiology of Steroid Biosynthesis, Transport and Metabolism in the Human Placenta
P2860
Q26999391-F73CC245-013A-40C2-BB0F-3668DFA021CFQ27027293-52DB97E2-6565-4247-803C-C3767EC67802Q27676875-11928E61-E995-4A74-B024-E8523A791F19Q28144397-388A476E-83EE-483B-BABF-16989139ECDFQ28254139-40B7E43D-4B70-443A-AB4F-0F76E3F9E938Q28264076-C29F94BF-D12C-4555-A2DD-C8363ED81D1DQ28371944-D94FA368-8AEB-4BF9-98B4-CD02AC62E6E4Q28393746-86193B49-8B21-495C-9004-718055FEFC1FQ33719834-1F53CAEC-1B32-40FF-95A9-1AA2738FEF01Q33759322-751EC7F7-FA76-4D6E-981C-5B24DCB2D647Q33916686-E35D990A-29B0-49A1-872A-949FB13AB8D4Q34182802-7A32D85C-8FE0-47D2-9E05-ED199DE52988Q35019769-1A77FD95-F319-4B54-A8A2-01967DCC0BA1Q35134727-A2BA0187-F454-4ED8-BB28-25C53DB81AFAQ36047153-0674BAA6-F899-4985-9EF9-B9065DB3916BQ36573320-475B49EA-D030-40B3-878D-D23E3C25B143Q36702463-3ED75D8E-0849-4952-B274-53FC626978D2Q36835803-AED599FF-B154-44EE-919E-B33A57E37D24Q36909306-3EA3166B-DE2C-4874-A07A-5C70EF77E281Q36909328-72F22B4F-0C12-4378-9EAB-F29F24FAF7CCQ37122394-7D2D30C4-84B2-4465-AFCE-C538FF99C6D9Q37550561-B22F9800-6EC8-4BA5-8F5E-F9B3B4367727Q37604379-C0C31684-4C6E-4A1C-8322-4FF2D9B431C9Q37899282-FB84B9B0-4D28-415F-A098-59CE644A03DEQ38135859-C94282B9-9769-4046-AEDB-A4F2143FE837Q44191834-938BF9C5-380E-465D-A9BD-5965A896C1BEQ46315115-50C10488-735E-4A1E-8BB1-7C9C5C240013Q47672239-7E2C6975-770C-4CEF-8DB4-C2E0AD462C4FQ47720012-D4568A62-4861-4FA1-96D5-FBB4891A63F8Q47840391-38C2FE2E-B09B-41FC-9904-6F267F2583A5Q58746190-E0BCD4C3-4FAC-46E6-ACBC-EC44EC4FD054
P2860
Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Detection of cytochrome P450 g ...... n first trimester of pregnancy
@ast
Detection of cytochrome P450 g ...... n first trimester of pregnancy
@en
Detection of cytochrome P450 g ...... n first trimester of pregnancy
@nl
type
label
Detection of cytochrome P450 g ...... n first trimester of pregnancy
@ast
Detection of cytochrome P450 g ...... n first trimester of pregnancy
@en
Detection of cytochrome P450 g ...... n first trimester of pregnancy
@nl
prefLabel
Detection of cytochrome P450 g ...... n first trimester of pregnancy
@ast
Detection of cytochrome P450 g ...... n first trimester of pregnancy
@en
Detection of cytochrome P450 g ...... n first trimester of pregnancy
@nl
P2093
P1476
Detection of cytochrome P450 g ...... n first trimester of pregnancy
@en
P2093
O Pelkonen
R Purkunen
S Saarikoski
T Cresteil
P304
P356
10.1016/0006-2952(96)00216-X
P407
P577
1996-07-26T00:00:00Z